SNY
Sanofi
Nasdaq: SNY · Paris, I0 · Healthcare
$44.24-0.09 (-0.20%)Closed
Market Cap$53.95B
Cash—most recent
Runway—
P/E (TTM)—
52-Wk Range$41.31 – $49.59
Avg Volume3.3M3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$44.24-16.3%
Pipeline

Drug candidates sponsored by Sanofi · ClinicalTrials.gov

88 drugs · 100 trials
PhaseDrug / CandidateIndicationsStatusNext CompletionTrials
Phase 4Meningococcal Polysaccharide Groups A\C\Y\W-135 Combined
Meningococcal Infections+1 more
Completed
2003-05past
1
Phase 4Enoxaparin sodium
Acute Coronary Syndrome
Completed
2005-02past
1
Phase 4Fludarabine Phosphate (Fludara)
Leukemia, Lymphocytic, Chronic, B-Cell
Completed
2005-09past
1
Phase 4Fluzone®: Influenza Virus Vaccine
Influenza
Completed
2006-02past
1
Phase 4Rasburicase
Hyperuricemia
Completed
2006-11past
1
Phase 4Enoxaparine
Hemodialysis
Completed
2007-04past
1
Phase 4Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib Vac
Diphtheria+4 more
Completed
2007-09past
1
Phase 4Ramipril-Felodipine
Hypertension
Completed
2008-04past
1
Phase 4Synvisc-One
Osteoarthritis
Completed
2011-09past
1
Phase 4Alglucosidase Alfa
Pompe Disease+5 more
Completed
2013-03past
2
Phase 4Insulin glargine
Diabetes Mellitus, Type 2+1 more
Completed
2017-11-27past
3
Phase 4Irbesartan/atorvastatin fixed dose combination
Type 2 Diabetes Mellitus
Completed
2018-04-19past
1
Phase 4Alirocumab SAR236553
Hypercholesterolemia+1 more
Completed
2018-07-27past
1
Phase 4Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Meningitis+2 more
Completed
2019-06-12past
1
Phase 4Laronidase
Mucopolysaccharidosis I+3 more
Terminated
2022-12-21past
1
Phase 4Dupilumab
Eosinophilic Oesophagitis+2 more
Recruiting
2027-05-24
3
Phase 4urate oxidase
Tumor Lysis Syndrome
Completed—1
Phase 4Leflunomide
Arthritis, Rheumatoid
Completed—1
Phase 3zolpidem-MR (modified release)
Sleep Initiation and Maintenance Disorders
Completed
2004-02past
1
Phase 3enoxaparin
Unstable Angina+2 more
Completed
2005-02past
1
Phase 3rimonabant (SR141716)
Obesity
Completed
2005-04past
1
Phase 2CELIVARONE (SSR149744C)
Atrial Fibrillation+1 more
Completed
2006-05past
1
Phase 3Granulocyte colony-stimulating factor plus plerixafor
Lymphoma, Non-Hodgkin
Completed
2006-07past
1
Phase 3Insulin glulisine
Diabetes Mellitus Type 2
Completed
2006-09past
1
Phase 3Levofloxacin
Pneumonia
Completed
2007-05past
1
Phase 3Saredutant
Depressive Disorder
Completed
2007-06past
1
Phase 3afuzosin
Benign Prostatic Hyperplasia
Completed
2007-10past
1
Phase 3Diphteria/Tetanus/Polio/Acellular Pertussis/Hib vaccine
Diphtheria+4 more
Completed
2008-04past
1
Phase 3Lactic Acid (Dermacyd PH_DETINBACK Tangerine Mix)
Hygiene
Completed
2008-09past
1
Phase 3Poliomyelitis Vaccine inactivated
Poliomyelitis+1 more
Completed
2008-09past
1
Phase 3Satavaptan
Ascites+1 more
Terminated
2008-10past
1
Phase 3Rimonabant
Prediabetic State
Terminated
2009-03past
1
Phase 3LACTIC ACID(ND)
Hygiene
Completed
2009-07past
1
Phase 3Sevelamer carbonate
Chronic Kidney Disease+1 more
Terminated
2009-09past
1
Phase 3REPEVAX
Healthy
Completed
2009-12past
1
Phase 2Docetaxel, Cisplatin, 5-fluorouracil (5-FU), radiotherapy
Head and Neck Neoplasms
Completed
2010-07past
1
Phase 3Lactic acid (Dermacid)
Hygiene
Completed
2010-12past
2
Phase 3JE-CV administered in Study JEC02
Encephalitis+1 more
Completed
2013-10-16past
1
Phase 3Insulin glargine new formulation (HOE901)
Type 2 Diabetes Mellitus
Completed
2013-11past
1
Phase 3INSULIN GLARGINE (U300)
Type 2 Diabetes Mellitus
Completed
2016-02past
1
Phase 3DTaP-IPV-Hep B-PRP~T combined vaccine
Diphtheria+5 more
Completed
2016-04past
1
Phase 3Insulin glargine/Lixisenatide (HOE901/AVE0010)
Type 2 Diabetes Mellitus
Completed
2018-05past
1
Phase 3Insulin glargine/lixisenatide fixed ratio combination
Type 2 Diabetes Mellitus
Completed
2018-05-25past
1
Phase 3Insulin aspart
Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus
Completed
2018-07-16past
1
Phase 3MenACYW conjugate vaccine
Meningitis, Meningococcal
Completed
2018-07-19past
1
Phase 3Placebo
Osteoarthritis
Completed
2019-01-28past
2
Phase 3sotagliflozin (SAR439954)
Type 2 Diabetes Mellitus
Terminated
2020-04-29past
1
Phase 3Nirsevimab
RSV Immunization+1 more
Completed
2024-03-27past
1
Phase 3Alirocumab
Hypercholesterolemia+1 more
Completed
2025-09-30past
2
Phase 3Rilzabrutinib
Immunoglobulin G4 Related Disease+1 more
Recruiting
2028-06-28
2
Phase 3Belumosudil
Lung Transplant Rejection
Recruiting
2029-01-29
1
Phase 3cisplatin
Lung Cancer
Completed—1
Phase 3FOLFOX regimen
Colorectal Cancer
Unknown—1
Phase 1CAMPATH (alemtuzumab)
Non-Hodgkin's Lymphoma
Terminated
2006-02past
1
Phase 2Inactivated, split-virion influenza vaccine
Influenza+2 more
Completed
2006-05past
1
Phase 2vandetanib
Lung Cancer
Completed
2006-12past
1
Phase 2Split, Inactivated, Trivalent Influenza Vaccine
Orthomyxoviridae Infection+2 more
Completed
2007-06past
1
Phase 2HOE140 Icatibant
Joint Disease
Completed
2007-07past
1
Phase 2Fluzone: Influenza virus vaccine
Influenza
Completed
2008-05past
1
Phase 2SSR180711C
Alzheimer's Disease
Terminated
2008-07past
1
Phase 2A/H5N1 inactivated, split-virion influenza virus
Influenza+1 more
Completed
2008-12past
1
Phase 2G-CSF plus plerixafor
Multiple Myeloma+3 more
Completed
2009-06past
2
Phase 2Bevacizumab (Avastin®)
Ovarian Cancer
Completed
2011-08past
1
Phase 2Docetaxel
Metastatic Prostate Cancer+1 more
Completed
2012-03past
2
Phase 2ombrabulin (AVE8062)
Non-small Cell Lung Cancer+1 more
Completed
2013-10past
2
Phase 1QIV-HD by IM
Influenza
Completed
2017-11-28past
1
Phase 1Tesevatinib
Polycystic Kidney, Autosomal Dominant
Completed
2019-02-08past
1
Phase 2Ferroquine SSR97193
Plasmodium Falciparum Infection
Terminated
2019-09-23past
1
Phase 2High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 μg (split-virion, inactivated)
Influenza
Completed
2019-10-16past
1
Phase 2Artefenomel (OZ439)
Plasmodium Falciparum Infection
Completed
2019-11-06past
1
Phase 1isatuximab SAR650984
Lymphoma
Terminated
2022-11-08past
1
Phase 1SAR446597
Geographic Atrophy
Recruiting
2027-10-13
1
Phase 2oxaliplatine / gemcitabine / Vinorelbine
Non Small Cell Lung Cancer
Completed—1
Phase 1aflibercept (AVE0005)
Cancer
Completed
2010-02past
1
Phase 1plerixafor
Chronic Lymphocytic Leukemia (CLL)+1 more
Completed
2010-11past
1
Phase 1Teriflunomide HMR1726
Renal Impairment
Completed
2011-02past
1
Phase 1Insulin glargine HOE901
Type 1 Diabetes Mellitus
Completed
2011-05past
1
Phase 1SAR231893 (REGN668)
Healthy
Completed
2012-10past
1
Phase 1ALX-0171
Respiratory Syncytial Virus Infection
Completed
2013-12past
1
Phase 1Recombinant human acid sphingomyelinase
Human Acid Sphingomyelinase Deficiency
Completed
2014-01past
1
Phase 1SAR125844
Malignant Solid Tumors
Completed
2016-04past
1
Phase 1SAR438544
Type 1 Diabetes Mellitus
Withdrawn
2016-11past
1
Phase 1Modified Release rhTSH
Healthy
Completed—1
N/AUnnamed
Medical Prevention Therapy
Completed
2010-06past
1
N/AUnnamed
Gaucher Disease, Splenomegaly+1 more
Completed
2024-11-25past
1
N/AUnnamed
Chlamydia Trachomatis
Completed
2025-12-31past
1
N/ATeplizumab
Diabetes Mellitus, Type 1
Active, not recruiting
2026-11
1
N/AUnnamed
Asthma
Recruiting
2029-04-04
1
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for SNY. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.